ArticleJMIR research protocols2025

Effectiveness, Engagement, and Safety of a Digital Therapeutic (CT-155/BI 3972080) for Treating Negative Symptoms in People With Schizophrenia: Protocol for the Phase 3 CONVOKE Randomized Controlled Trial.

Shaheen E Lakhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.